Giant-cell arteritis is a systemic vasculitis with limited treatment options. The efficacy and safety of upadacitinib — a ...

A 2-month-old boy was brought to the clinic with a 2-week history of red spots on his face. On examination, annular plaques with edematous borders and central crusting were observed on his face, ...

Pulmonary-vein isolation is an effective treatment for paroxysmal atrial fibrillation. Pulsed field ablation (PFA) is a nonthermal ablation method with few adverse effects beyond the myocardium.

Five risk factors account for approximately 50% of the global burden of cardiovascular disease. How the presence or absence of classic risk factors affects lifetime estimates of cardiovascular ...

Transcatheter aortic-valve implantation (TAVI) is associated with procedure-related stroke. Cerebral embolic protection (CEP) devices may reduce embolization to the cerebral circulation and hence ...

In patients with active cancer and venous thromboembolism, whether extended treatment with a reduced dose of an oral anticoagulant is effective in preventing recurrent thromboembolic events and ...

The cardiovascular safety of oral semaglutide, a glucagon-like peptide 1 receptor agonist, has been established in persons with type 2 diabetes and high cardiovascular risk. An assessment of the ...

The primary mission of medical schools is to train physicians who will provide excellent patient care. Pass/fail grading systems, in their current form, could threaten that goal.

Most U.S. medical school applicants now log many hours shadowing physicians to boost their chances of admission, but these experiences may not be beneficial, they have costs, and access to them is ...

Residency applicants have long been advised to play it safe in their personal statement, but what if the best way to rise above the heap is to share a part of yourself you’ve been told to keep ...

IgG4-related disease is a multiorgan, relapsing, fibroinflammatory, immune-mediated disorder. It is characterized by the development of mass lesions rich in CD19+ B cells that may drive ...

A 59-year-old man with a history of metabolic dysfunction–associated steatotic liver disease had an enlarging liver mass. Biopsy showed hepatocellular carcinoma. Management decisions were made.